We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Efficacy and toxicity of external-beam radiation therapy for localised prostate cancer: a network meta-analysis.
- Authors
Zhu, Z; Zhang, J; Liu, Y; Chen, M; Guo, P; Li, K
- Abstract
Background:Many radiation regimens for treating prostate cancer have been used over the years, but which regimen is optimal for localised or locally advanced prostate cancer lacks consensus. We performed a network meta-analysis to identify the optimal radiation regimen.Methods:We systematically reviewed data from 27 randomised controlled trials and could group seven radiation regimens as follows: low- and high-dose radiation therapy (LDRT and HDRT), LDRT+ short- or long-term androgen deprivation therapy (LDRT+SADT and LDRT+LADT), HDRT+SADT, hypofractionated radiotherapy (HFRT), and HFRT+SADT. The main outcomes were overall mortality (OM), prostate-specific antigen (PSA) failure, cancer-specific mortality, and adverse events.Results:For the network meta-analysis of 27 trials, LDRT+LADT and LDRT+SADT were associated with decreased risk of OM as compared with LDRT alone as was LDRT+LADT compared with HDRT. Apart from HFRT, all other treatments were associated with decreased risk of PSA failure as compared with LDRT. HFRT+SADT was associated with decreased risk of cancer-specific mortality as compared with HFRT, LDRT+SADT, HDRT, and LDRT.Conclusions:HFRT+SADT therapy might be the most efficacious treatment but with worst toxicity for localised or locally advanced prostate cancer, and HDRT showed excellent efficacy but more adverse events.
- Subjects
PROSTATE cancer treatment; CANCER radiotherapy; TOXICOLOGY; ADVERSE health care events; PROSTATE-specific antigen; META-analysis
- Publication
British Journal of Cancer, 2014, Vol 110, Issue 10, p2396
- ISSN
0007-0920
- Publication type
Article
- DOI
10.1038/bjc.2014.197